Abstract |
|
Authors | Shinji Nakamichi, Kaoru Kubota, Hidehito Horinouchi, Shintaro Kanda, Yutaka Fujiwara, Hiroshi Nokihara, Noboru Yamamoto, Tomohide Tamura |
Journal | Japanese journal of clinical oncology
(Jpn J Clin Oncol)
Vol. 43
Issue 4
Pg. 422-5
(Apr 2013)
ISSN: 1465-3621 [Electronic] England |
PMID | 23410901
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Protein Kinase Inhibitors
- Quinazolines
- Erlotinib Hydrochloride
- ErbB Receptors
- Gefitinib
|
Topics |
- Adenocarcinoma
(pathology)
- Antineoplastic Agents
(adverse effects)
- ErbB Receptors
(metabolism)
- Erlotinib Hydrochloride
- Female
- Gefitinib
- Humans
- Lung Diseases, Interstitial
(chemically induced)
- Lung Neoplasms
(pathology)
- Meningeal Carcinomatosis
(drug therapy, secondary)
- Middle Aged
- Protein Kinase Inhibitors
(therapeutic use)
- Quinazolines
(adverse effects, therapeutic use)
|